ITW
55
2
SBUX
39
4
LLY
70
2
CMS
67
2
ADBE
33
-16
NKE
43
6
GLW
72
5
BK
61
3
EIX
64
3
ADT
32
2
UNM
66
4
KSS
28
-26
ACN
42
-5
BWA
48
12
HBI
45
2
MET
48
3
MKC
35
5
SEE
46
4
KLAC
65
-2
VRSK
75
2
ITW
55
2
SBUX
39
4
LLY
70
2
CMS
67
2
ADBE
33
-16
NKE
43
6
GLW
72
5
BK
61
3
EIX
64
3
ADT
32
2
UNM
66
4
KSS
28
-26
ACN
42
-5
BWA
48
12
HBI
45
2
MET
48
3
MKC
35
5
SEE
46
4
KLAC
65
-2
VRSK
75
2
Financhill
Back

Cerus Vs. Perspective Therapeutics Industry Stock Comparison

Sell
45

CERS
Cerus

Last Price:
1.78
Seasonality Move:
7.66%
Sell
45

CATX
Perspective Therapeutics

Last Price:
1.40
Seasonality Move:
17.15%
Sell
45
Cerus (CERS) is a Sell

Is Cerus a Buy, Sell or Hold?

  • The current Cerus [CERS] share price is $1.79. The Score for CERS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CERS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $1.38. The Score for CATX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CERS Stock Price Chart

What is Cerus's stock price today?

  • The Cerus share price today is $1.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CERS is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $1.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

CERS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 46.63 Sell
Chaikin Money Flow: -238625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.73 - 1.95) Sell
Bollinger Bands (100): (1.72 - 2.14) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 39.69 Sell
Chaikin Money Flow: -4106345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.48 - 1.78) Sell
Bollinger Bands (100): (0.79 - 1.59) Buy

CERS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.83 Sell
20-day SMA: 1.87 Sell
50-day SMA: 1.8 Sell
200-day SMA: 1.81 Sell
8-day EMA: 1.83 Sell
20-day EMA: 1.84 Sell
50-day EMA: 1.86 Sell
200-day EMA: 2.01 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.46 Sell
20-day SMA: 1.62 Sell
50-day SMA: 1.53 Sell
200-day SMA: 0.75 Buy
8-day EMA: 1.45 Sell
20-day EMA: 1.54 Sell
50-day EMA: 1.47 Sell
200-day EMA: 0.96 Buy

Cerus Earnings Growth & CERS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.

Cerus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):